Ad
AMGN Stock - Amgen Stock Trading
About | Amgen Inc. (NASDAQ:AMGN)
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Quote | Amgen Inc. (NASDAQ:AMGN)
| Last: | $288.56 |
|---|---|
| Change Percent: | 0.7% |
| Open: | $281.12 |
| Close: | $288.56 |
| High: | $289.9 |
| Low: | $279.06 |
| Volume: | 2,146,618 |
| Last Trade Date Time: | 04/29/2025 03:40:31 pm |
News | Amgen Inc. (NASDAQ:AMGN)
-
2025-04-29 16:39:10 ET Following are the Top 5 companies based on their one-day percentage change within the 'TOP US - Healthcare Companies' theme. Pfizer Inc. (PFE) PFE is trading UP for the last 4 days, and it at trading at $23.87 with volume of 75,865,818 and a one day change...
-
2025-04-28 17:33:03 ET Summary Zymeworks is rated Strong Buy due to its improved outlook, FDA approval of Ziihera, advancing pipeline, and strong cash position. Zanidatamab (Ziihera) is a key asset with accelerated approval for HER2+ BTC and multiple ongoing trials in high-value i...
Message Board Posts | Amgen Inc. (NASDAQ:AMGN)
| Subject | By | Source | When |
|---|---|---|---|
| AMGEN INC is having a great day! | MiamiGent | investorshub | 11/08/2022 5:04:41 PM |
| whytestocks: $AMGN News Article - Why Amgen Is Up More Than 6% Today | whytestocks | investorshangout | 10/11/2022 6:45:49 PM |
| whytestocks: $AMGN News Article - AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS RE | whytestocks | investorshangout | 02/08/2022 4:25:52 PM |
| WAS SUPPOSED TO BE BIG IN pm | ernie44 | investorshub | 02/04/2022 2:30:34 PM |
| I was reading on another board where someone | all the way up green | investorshub | 01/05/2022 4:44:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Amgen Inc. Company Name:
AMGN Stock Symbol:
NASDAQ Market:
0.7% G/L:
$288.56 Last:
2,146,618 Volume:
$281.12 Open:
$288.56 Close:
Amgen Inc. Website:
Ad
-
2025-04-29 16:39:10 ET Following are the Top 5 companies based on their one-day percentage change within the 'TOP US - Healthcare Companies' theme. Pfizer Inc. (PFE) PFE is trading UP for the last 4 days, and it at trading at $23.87 with volume of 75,865,818 and a one day change...
-
2025-04-28 16:39:07 ET Following are the Top 5 companies based on their one-day percentage change within the 'TOP US - Healthcare Companies' theme. AbbVie Inc. (ABBV) ABBV is trading UP for the last 5 days, and it at trading at $192.71 with volume of 7,548,683 and a one day chan...
-
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS PR Newswire THOUSAND OAKS, Calif. , April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025 , afte...